Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS ISSUE:
June 2011

Duloxetine and Venlafaxine: Where They Fit in an MDD Treatment Algorithm
There is no evidence that SNRIs are superior to SSRIs for the treatment of depression.

Ziprasidone Enhances Weight Loss in Patients with Bipolar Disorder
Adjunctive ziprasidone (Geodon) may help facilitate weight loss in overweight patients with bipolar disorder.

Lamotrigine Fails as an Augmenter in TRD
The first large trial of adjunctive lamotrigine (Lamictal and others) for treatment-resistant depression failed to find a statistically significant advantage of lamotrigine over placebo.

In Brief
Treatments for autism spectrum disorders are reviewed.

Light Therapy for Depression during Pregnancy
A small study found significant benefit for bright light therapy for pregnant women with depression.

Reboxetine: Less than Meets the Eye
A review and meta-analysis found reboxetine less effective than SSRIs for the acute treatment of depression and more likely than placebo to cause adverse effects.

Duloxetine and Venlafaxine: Where They Fit in an MDD Treatment Algorithm

June 2011

There are many first-line medication treatment options for major depressive disorder (MDD). But there is little science to guide choices.1 In July 2009, we highlighted a comparative-efficacy, multiple-treatments meta-analysis from Cipriani et al (BTP 2009;32:25).2 They…

To view the rest of this article, please: